Corcept Therapeutics
CORT
#2410
Rank
C$8.51 B
Marketcap
$80.70
Share price
1.03%
Change (1 day)
151.18%
Change (1 year)

Operating Margin for Corcept Therapeutics (CORT)

Operating Margin as of March 2025 (TTM): 23.92%

According to Corcept Therapeutics 's latest financial reports and stock price the company's current Operating Margin is 23.92%. At the end of 2024 the company had an Operating Margin of 23.92%.

Operating Margin history for Corcept Therapeutics from 2006 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202423.92%-7.35%
202325.82%-10.69%
202228.91%-15.35%
202134.16%-8.15%
202037.19%-2.31%
201938.07%3.79%
201836.68%10.58%
201733.17%231.37%
201610.01%-178.55%
2015-12.74%-89.22%
2014-118.20%-73.39%
2013-444.25%-61.39%
2012-1,150.53%
2009-69,827.59%641.22%
2008-9,420.57%270.82%
2007-2,540.46%-70.8%
2006-8,701.36%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
18.78%-21.49%๐Ÿ‡บ๐Ÿ‡ธ USA
-17.34%-172.49%๐Ÿ‡บ๐Ÿ‡ธ USA
26.37% 10.24%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
28.15% 17.68%๐Ÿ‡บ๐Ÿ‡ธ USA
12.60%-47.32%๐Ÿ‡บ๐Ÿ‡ธ USA
31.06% 29.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-179.86%-851.92%๐Ÿ‡บ๐Ÿ‡ธ USA
10.68%-55.35%๐Ÿ‡บ๐Ÿ‡ธ USA
18.98%-20.65%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.